• Title/Summary/Keyword: Cyclophosphamide

Search Result 369, Processing Time 0.032 seconds

A Case of Systemic Lupus Erythematosus with Recurrent Transverse Myelitis (재발횡단척수염과 동반한 전신홍반루푸스 1예)

  • Lee, Jun-Hwan;Park, Ki-Jong;Lee, Sang-Il;Kwon, Oh-Young;Kang, Heeyoung;Kang, Jong-Su;Park, Eu-Jung;Choi, Nack-Cheon;Lim, Byeong Hoon
    • Annals of Clinical Neurophysiology
    • /
    • v.9 no.1
    • /
    • pp.29-32
    • /
    • 2007
  • Recurrent transverse myelitis is a rare manifestation of systemic lupus erythematosus. Recurrent transverse myelitis presents the biggest diagnostic problem, since it is common manifestation of multiple sclerosis. But it can also be the only feature or first manifestation in systemic lupus erythematosus. Neurological manifestations and magnetic resonance imaging can be indistinguishable, and there are no specific diagnostic tools. Here we describe a 59-year-old female having a systemic lupus erythematosus with recurrent transverse myeltitis. No uniform therapeutic protocol exists for systemic lupus erythematous with transverse myelitis, and the prognosis is usually poor. We suggest that aggressive treatment (usually with pulses of methylprednisolone and cyclophosphamide) might improve the prognosis of systemic lupus erythematosus with transverse myeltis.

  • PDF

Pulmonary Cavitary Lesions Associated with High Fever (고열을 동반한 폐의 공동성 병변)

  • Lee, So-Hyeon;Pyun, Eun-Kyung;Lee, Hye-Jin;Lee, Jin-Hwa;Cho, Young-Joo;Han, Woon-Sup;Kim, Hyae-Young;Park, Sung-Sook;Chang, Jung-Hyun
    • Tuberculosis and Respiratory Diseases
    • /
    • v.49 no.5
    • /
    • pp.644-648
    • /
    • 2000
  • A 35-year-old male presented high fever and cough. The pateint showed three, discrete, "punched-out", shallow ulcers appearing as pyodermic gangrenosum on the trunk and the back, and a painless subcutaneous nodule on the medial side of the left thigh. The chest X-ray showed multiple cavities on the both lungs. The diagnosis of Wegener's granulomatosis was established by pathology of the skin and the lung, radiologic findings of the chest and positive result of c-ANCA test.

  • PDF

A Case of Neuroblastoma Presenting with Sudden Blindness (실명을 주소로 한 신경아세포종 1예)

  • Ma, In-Youl;Hah, Jeong-Ok;Kim, Chun-Dong;Lee, Tae-Sook
    • Journal of Yeungnam Medical Science
    • /
    • v.2 no.1
    • /
    • pp.259-264
    • /
    • 1985
  • Neuroblastoma is the most common extracranial solid tumor of childhood which presents various clinical symptoms depending on the primary and metastatic sites. However, it has been rarely reported that sudden onset of blindness was the chief complaint of neuroblastoma. A four years old boy was admitted to the Yeungnam University Hospital with the chief complaint of a sudden onset of blindness due to a distant metastasis of abdominal neuroblastoma to the sphenoid sinus. On admission, both side pupils were dilated without light reflex, fundoscopy showed pale optic disk, electroretinogram was subnormal and visual evoked potential showed no response. The liver was palpable in $3{\frac{1}{2}}$ finger breadth from the right costal margin and adult fist sized mass was palpable in the right flank. Skull X-ray showed destructed sphenoid bone and clinoid process and brain CT scan showed tumor mass in the sphenoid sinus and left orbit. Ultrasonogram and CT scan of the abdomen showed large tumor masses around the right kidney and para-aortic and retropancreatic lymph node. IVP showed displaced right calyceal system with preserved contour. Left supraclavicular lymph node which appeared after admission was biopsied and it showed poorly differentiated neuroblasts. He was treated according to the multiagent chemotherapy schedule for stage IV neuroblastoma patient of children's cancer study group. Abdominal tumor masses and sphenoid sinus mass were markedly reduced after 2 courses of the combination chemotherapy of cyclophosphamide, vincristine, DTIC, adriamycin and VM-26. Eventhough the blindness was not improved, the patient has been in good clinical condition.

  • PDF

The Effect of Ginseng Saponin Fractions on Humoral Immunity of Mouse (생쥐의 체액성 면역에 미치는 인삼사포닌 분획물들의 영향)

  • Park, Han-U;Kim, Se-Chang;Jeong, No-Pal
    • Journal of Ginseng Research
    • /
    • v.12 no.1
    • /
    • pp.63-67
    • /
    • 1988
  • To investigate the effect of ginseng saponin fractions (total saponin, diol saponin and triol saponin) on the antibody production and on the recovery of immunosuppression in mouse, chick ${\gamma}$-globulin was used as immunogen and CY(cyclophosphamide) as immunosuppressive drug. The effect of ginseng saponin fractions on the production of total serum protein was investigated also. Circulating antibody was measured with ELISA method. Total saponin, dial saponin and triol saponin resulted 4 times higher titer values compared to control group in the production of antibody but resulted no effect on the recovery of immunosuppression induced by CY. From the above results ginseng saponin fractions are believed to effect on intact immune system and to promote antibody production by helping the cooperations among lymphocytes or the growth of lymphocytes. And the increase of total serum protein has no direct relations with the increase of circulatory antibody.

  • PDF

Effects of Cordyceps militaris on Immune Activity (밀리타리스 동충하초(Cordyceps militaris)의 면역 활성에 미치는 영향)

  • Kang, In Soon;Kim, Hyeju;Lee, Tae Ho;Kwon, Yong Sam;Son, Miwon;Kim, Chaekyun
    • YAKHAK HOEJI
    • /
    • v.58 no.2
    • /
    • pp.81-90
    • /
    • 2014
  • In order to determine the functional benefits of Cordyceps militaris in the immune system, we examined the immunomodulatory activities of C. militaris using an immunocompromised C57BL/6 mice, mouse spleen cells, RAW 264.7 macrophage cells, and A549 lung carcinoma cells. Mice were injected intraperitioneally with an immunosuppressive drug, cyclophosphamide, and then administered orally with 30, 100 and 300 mg/kg of 50% ethanol extract of C. militaris (CME 30, CME 100 and CME 300) for 14 days. CME increased splenocyte proliferation and natural killer (NK) cell activity compared to 3% hydroxypropyl methylcellulose-treated control mice. CME also increased the production of Th1 cytokines, IL-2 and TNF-${\alpha}$ in spleen cells isolated from CME-injected mice and in vitro, which suggested the enhanced cellular immunity in response to CME. CME also increased splenocyte proliferation, NK cell activity, and IL-2 and TNF-${\alpha}$ production compared to 1 ${\mu}M$ methotrexate-treated spleen cells in vitro. We examined whether C. militaris regulates the production of inflammatory mediators in LPS-stimulated RAW 264.7 cells. CME inhibited LPS-induced NO production and iNOS expression in a dose dependent manner, while COX-2 expression was remained unchanged. In addition, CME also has free radical scavenging activity, indicating its antioxidant activity. These results indicate that C. militaris enhances immune activity by promoting immune cell proliferation and cytokine production.

Augmentation of the Cytotoxic Effects of Anticancer Drugs by $(\pm)$-ar-Turmerone and Extracts of the Lithosperma and Scutellaria Roots against Human Leukemia Cell Lines (백혈병 세포주에 대한 $(\pm)$-ar-Turmerone, 자근 및 황금추출물에 의한 항암제의 세포독성 증강효과)

  • 이윤영;유관희;김삼용;안병준
    • YAKHAK HOEJI
    • /
    • v.35 no.3
    • /
    • pp.203-215
    • /
    • 1991
  • Using the calorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT)assay, we evaluated the chemosensitivity of 8 anticancer drugs{vincristine(VCR), vinblastine(VBL), adriamycin(ADR), cisplatin(CPDD), etoposide(VP-16), cytosine arabinoside(ara-C), bleomycin (Bleo) and cyclophosphamide(CYC)} and the cytotoxicity-enhancing effects of ($\pm$)-ar-turmerone and the extracts of the crude drugs {Lithospermum eythrorhizon(LE) and Scutellaria baicalensis (SB)} on the above mentioned anticancer drugs against HL-60 and KG-1 cells among 8 anticancer drugs, VCR, VBL, ADR, and CPDD inhibited the growth of both cell lines by more than 50%, while VP-16, ara-C, Bleo, and CYC were less effective. ($\pm$)-ar-Turmerone had significant inhibitory effects against both cell lines, showing the ID$_{50}$ values of 11.730 $\mu\textrm{g}$/ml and 0.292 $\mu\textrm{g}$/ml for HL-60 and KG-1 cells. respectively. But the extracts of LE and SB roots showed no significant cytotoxic effects. According to ID$_{50}$ values, the cytotoxicities of VCR, VBL and ADR against HL-60 were enhanced two, eight and three times by mixing ($\pm$)-ar-turmerone, five, seven and three times by adding the extract of LE root, and twenty, six and three times by mixing the extract of SB root, respectively. The cytotoxicities of the above mentioned drugs against KG-1 cell were enhanced two, seven and three times by mixing ($\pm$)-ar-turmerone, two, three and three times by combining wilth the extract of LB root, and two, five and two times by adding the extract of SB root, respectively. The cytotoxicity-potentiating effects of ($\pm$)-ar-turmerone and the extracts of LE and SB roots against HL-60 cell were greater than KG-1 cell.

  • PDF

A Case of Wegener's Granulomatosis that Presented as a Single Lung Mass (단일 폐종괴로 발견된 Wegener 육아종증 1예)

  • Oh, In Jae;Jeong, Jong Pil;Kim, Soo Ok;Son, Jun Gwang;Ban, Hee Jung;Lim, Jung Hwan;Cho, Gye Jung;Ju, Jin Young;Kim, Kyu Sik;Kim, Yu Il;Lim, Sung Chul;Kim, Young Chul
    • Tuberculosis and Respiratory Diseases
    • /
    • v.63 no.1
    • /
    • pp.88-93
    • /
    • 2007
  • Wegener's granulomatosis is a disease with an unknown etiology that is characterized by necrotizing granulomatous vasculitis involving the upper and lower respiratory tract and the kidneys. The typical pulmonary findings are bilaterally involved multiple variable sized nodules. We report a case of Wegener's granulomatosis that presented as a single lung mass. A male patient presented with a nasal obstruction, arthralgia, cough, and intermittent dyspnea. The chest radiograph showed a mass, approximately 4.5 cm in diameter, in the right lower lobe. Lung cancer or tuberculosis was initially considered. However, the clinical, laboratory and pathological findings of the mass indicated Wegener's granulomatosis. The patient was administered prednisolone and cyclophosphamide, and improved temporarily. Unfortunately, the immunocompromised patient expired as a result of respiratory failure with pneumonia.

Second Trial of Cyclosporin A-Induced Remission in Other Immunosuppressant Therapy-Resistant FSGS Patient (다른 면역 억제제에 듣지 않는 국소성 분절성 사구체 경화증 환자에서 Cyclosporin A 2차 치료에 의한 완해 경험)

  • Cho Hee-Yeon;Lee Bum-Hee;Kang Ju-Hyung;Ha Il-Soo;Cheong Hae-Il;Choi Yong
    • Childhood Kidney Diseases
    • /
    • v.9 no.1
    • /
    • pp.83-90
    • /
    • 2005
  • Focal segmental glomerulosclerosis(FSGS) has been detected in approximately 10% of cases of Idiopathic nephrotic syndrome in children, and exhibits a poor response to initial steroid therapy, as well as a higher rate of progression to chronic renal failure and relapse after kidney transplantation. We describe a case of an eleven year-old boy with steroid-resistant FSGS who exhibited a response to a second trial of cyclosporin h(CsA) therapy. At the age of 26 months, this patient was diagnosed with steroid-resistant FSGS. For 9 years, he had undergone a gauntlet of therapies to induce remission; oral steroids, cyclophosphamide, methylprednisolone(mehyIPd) pulse therapy, CsA, and ibuprofen therapy. Although these therapies failed to induce remission, the patient's renal function remained In the normal range during the nine years of treatment. At the age of ten years, the patient's proteinuria decreased, and complete remission was attained with a second administration of CsA, coupled with a low dose of oral steroids. This patient continues to receive CsA without relapse. Therefore, our major concern involves the possibility of relapse after the discontinuation of CsA therapy Our findings in this case suggest that, in cases of refractory FSGS, if renal insufficiency does not emerge, aggressive therapy for the amelioration of proteinuria should be continuously pursued.

  • PDF

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia

  • Lee, Jongmin;Kim, Yong Hyun;Kang, Ji Young;Jegal, Yangjin;Park, So Young;Korean Interstitial Lung Diseases Study Group
    • Tuberculosis and Respiratory Diseases
    • /
    • v.82 no.4
    • /
    • pp.277-284
    • /
    • 2019
  • Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Clinical manifestations include subacute or chronic dyspnea and cough that last an average of 6 months, most of which occur in non-smoking, middle-aged women. The common findings in thoracic high-resolution computed tomography in NSIP are bilateral reticular opacities, traction bronchiectasis, reduced volume of the lobes, and ground-glass opacity in the lower lungs. These lesions can involve diffuse bilateral lungs or subpleural area. Unlike usual interstitial pneumonia, honeycombing is sparse or absent. Pathology shows diffuse interstitial inflammation and fibrosis which are temporally homogeneous, namely NSIP pattern. Idiopathic NSIP is usually treated with steroid only or combination with immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine, and mycophenolate mofetil. Prognosis of idiopathic NSIP is better than idiopathic pulmonary fibrosis. Many studies have reported a 5-year survival rate of more than 70%.

Glycine max Fermented by a Novel Probiotic, Bifidobacterium animalis subsp. lactis LDTM 8102, Increases Immuno-Modulatory Function

  • Kim, Jae Hwan;Jeong, Minju;Doo, Eun-Hee;Koo, Young Tae;Lee, Seon Joo;Jang, Ji Won;Park, Jung Han Yoon;Huh, Chul Sung;Byun, Sanguine;Lee, Ki Won
    • Journal of Microbiology and Biotechnology
    • /
    • v.32 no.9
    • /
    • pp.1146-1153
    • /
    • 2022
  • Many probiotic species have been used as a fermentation starter for manufacturing functional food materials. We have isolated Bifidobacterium animalis subsp. lactis LDTM 8102 from the feces of infants as a novel strain for fermentation. While Glycine max has been known to display various bioactivities including anti-oxidant, anti-skin aging, and anti-cancer effects, the immune-modulatory effect of Glycine max has not been reported. In the current study, we have discovered that the extract of Glycine max fermented with B. animalis subsp. lactis LDTM 8102 (GFB 8102), could exert immuno-modulatory properties. GFB 8102 treatment increased the production of immune-stimulatory cytokines in RAW264.7 macrophages without any noticeable cytotoxicity. Analysis of the molecular mechanism revealed that GFB 8102 could upregulate MAPK2K and MAPK signaling pathways including ERK, p38, and JNK. GFB 8102 also increased the proliferation rate of splenocytes isolated from mice. In an animal study, administration of GFB 8102 partially recovered cyclophosphamide-mediated reduction in thymus and spleen weight. Moreover, splenocytes from the GFB 8102-treated group exhibited increased TNF-α, IL-6, and IL-1β production. Based on these findings, GFB 8102 could be a promising functional food material for enhancing immune function.